Anybody has any opinions on today's CLVS ESMO abstract? It was good enough to move it $2 https://twitter.com/DionCapital/status/512225302270181376/photo/1 ARIEL-2 Abstract: Rucaparib ORR 68% in BRCA-wt pts, validates HRD approach